ZYPITAMAG is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Medicure International Inc. The primary component is Pitavastatin.
Product ID | 25208-200_07378b11-02d3-40f6-bea5-90ac775b04ed |
NDC | 25208-200 |
Product Type | Human Prescription Drug |
Proprietary Name | ZYPITAMAG |
Generic Name | Pitavastatin Magnesium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2021-05-31 |
Marketing Category | NDA / NDA |
Application Number | NDA208379 |
Labeler Name | Medicure International Inc |
Substance Name | PITAVASTATIN |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA],HMG-CoA Reductase Inhibitor [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2018-03-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2019-10-01 |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2019-10-01 |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2019-10-01 |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2021-05-31 |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2019-10-01 |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2020-07-31 |
Marketing Category | NDA |
Application Number | NDA208379 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-03-09 |
Marketing End Date | 2019-10-01 |
Ingredient | Strength |
---|---|
PITAVASTATIN | 1 mg/1 |
SPL SET ID: | c8c50e03-5cb8-43f4-bdef-8edd12f1945f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
25208-200 | ZYPITAMAG | Pitavastatin Magnesium |
25208-201 | ZYPITAMAG | Pitavastatin Magnesium |
25208-202 | ZYPITAMAG | Pitavastatin Magnesium |
70771-1116 | ZYPITAMAG | Pitavastatin Magnesium |
70771-1117 | ZYPITAMAG | Pitavastatin Magnesium |
70771-1118 | ZYPITAMAG | Pitavastatin Magnesium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZYPITAMAG 87730057 not registered Live/Pending |
Cadila Healthcare Limited 2017-12-21 |